Company Filing History:
Years Active: 2015
Title: Rongxin Deng: Innovator in Tumor Treatment
Introduction
Rongxin Deng is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of cancer treatment through his innovative research and development of novel compounds.
Latest Patents
Deng holds a patent for "Gambogenic acid derivatives, preparation method and application thereof." This patent describes gambogenic acid derivatives that exhibit a structure shown as Formula (I) or (II), along with their salts, preparation methods, and applications in tumor treatment. Compared to gambogenic acid, these derivatives demonstrate more potent anti-tumor activities, showcasing their potential in medical applications.
Career Highlights
Rongxin Deng is affiliated with Shanghai Jiao Tong University, where he conducts his research. His work focuses on developing effective treatments for tumors, contributing to advancements in oncology.
Collaborations
Some of his notable coworkers include Wantao Chen and Xu Wang, who collaborate with him on various research projects.
Conclusion
Rongxin Deng's innovative work in developing gambogenic acid derivatives highlights his commitment to improving cancer treatment. His contributions to the field are invaluable and pave the way for future advancements in oncology.